2025 Oncology Institute
August 13, 2025 | 12:00 AM EST
- Home
- Clinical Resources Search
- PQI Podcast S6 Ep 7: Urology Clinic Best Practices
S6 Eps 7: Urology Clinic Best Practices
Last Updated: February 29, 2024
By: Ginger Blackmon, PharmD | Melanie Boren MHA, RN, BSN, OCN | Robin Carr
In this episode, we welcome the dynamic duo from Central Ohio Urology Group, Melanie Boren MHA, RN, BSN, OCN, and Robin Carr. Join us as they dive into how their multidisciplinary team collaborates to deliver top-tier patient care.
Melanie is the Director of Oncology Operations at Central Ohio Urology Group. She has worked in the oncology setting for 25 years. Robin is the Lead Pharmacy Tech at Central Ohio Urology Group. She oversees all dispensing of medications at two locations and has been a Pharmacy Technician for 35 years.
Related Content
PQI Podcast
PQI Podcast
PQI Podcast
PQI Podcast
S8 Ep 13: Supporting Patients Through Financial Assistance
Author: Ginger Blackmon, PharmD | Michael Heimall, FACHE
Last Updated: 05/20/2025
S8 Bonus Episode: ¡No Más Melanomas! – Updates in the Treatment of Cutaneous Melanoma
Author: Ginger Blackmon, PharmD | Kendra Rodriguez
Last Updated: 05/20/2025
S8 Ep 12: Lorlatinib in Practice: 5 Years of Data, Real-World Counseling, and AE Management
Author: Ginger Blackmon, PharmD | Stefanie Houseknecht, PharmD, BCOP | Monica Chintapenta, PharmD, BCOP
Last Updated: 05/20/2025
S8 Ep 11: Honoring Her Legacy: A Conversation with Miss America 2024
Author: Ginger Blackmon, PharmD | Madison Marsh
Last Updated: 05/20/2025
PQI
PQI
PQI
PQI
PQI: Use of Rucaparib (Rubraca®) and Indications
Author: Jon Suyko Pharm.D., BCPS
Last Updated: 05/20/2025
PQI: Talazoparib (Talzenna®) and Enzalutamide (Xtandi®) in HRR Gene-Mutated Metastatic Castration-Resistant Prostate Cancer
Author: Kathleen Burns, MSN, NP
Last Updated: 05/20/2025
PQI: Radium Ra 223 Dichloride (Xofigo®) Management
Author: Jill Boyett, PharmD, CPh
Last Updated: 05/20/2025
PQI: Olaparib (Lynparza®) Clinical Management
Author: Katie Carter, PharmD, BCPS
Last Updated: 05/20/2025
PQI
PQI
PQI in Action
PQI in Action
PQI: Enfortumab Vedotin-ejfv (Padcev®) and Pembrolizumab (Keytruda®) Management for Advanced or Metastatic Urothelial Carcinoma
Author: Andrew Ruplin, PharmD
Last Updated: 05/20/2025
PQI: Enfortumab Vedotin-ejfv (Padcev®) Management for Advanced or Metastatic Urothelial Carcinoma
Author: Andrew Ruplin, PharmD
Last Updated: 05/20/2025
PQI in Action: Enfortumab Vedotin (Padcev®) Management for Advanced or Metastatic Urothelial Carcinoma – 2
Author: City of Hope, IL | City of Hope, GA | Baptist MD Anderson Cancer Center, FL
Last Updated: 05/20/2025
PQI in Action: Enfortumab Vedotin (Padcev®) Management for Advanced or Metastatic Urothelial Carcinoma
Author: Seattle Cancer Care Alliance, WA | Georgia Cancer Specialists, GA
Last Updated: 05/20/2025
PQI
PQI in Action
PQI
PQI Podcast
PQI: Zolbetuximab (Vyloy®) for Gastroesophageal Cancers
Author: Dr. Reetu Mukherji, MD
Last Updated: 05/20/2025
PQI in Action: Larotrectinib (Vitrakvi®) Overview
Author: Upstate Cancer Center/Upstate Golisano Children’s Hospital, NY | Wolfson Children’s Hospital, FL
Last Updated: 05/20/2025
PQI: Advances in MRD Monitoring for Diffuse Large B-Cell Lymphoma (DLBCL)
Author: Tara Graff, DO, MS
Last Updated: 05/20/2025
S8 Ep 13: Supporting Patients Through Financial Assistance
Author: Ginger Blackmon, PharmD | Michael Heimall, FACHE
Last Updated: 05/20/2025